Skip to main content
logo
Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India flag India · Delayed Price · Currency is INR
177.50
+5.00 (2.90%)
Oct 1, 2026, 3:12 PM IST

NSE:MADHAVBAUG Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,0691,069917.04993.31991.69747.11
Revenue Growth
9.10%16.58%-7.68%0.16%32.74%42.92%
Gross Profit
855.63855.63708.22713.7692.76505.86
Operating Income
92.992.9119.513.6252.5948.18
Net Income
89.8789.8771.3619.848.3334.69
Earnings Per Share
8.048.045.781.574.603.30
EPS Growth
3.61%39.10%268.15%-65.85%39.32%487.10%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
230.65230.65157.02183.59155.59191.68
Total Debt
25.8525.8514.7716.781.3410.63
Net Cash (Debt)
204.79204.79142.24166.81154.25181.05
Net Cash Growth
43.85%43.98%-14.73%8.14%-14.80%-
Net Cash Per Share
18.3118.3111.5313.5214.6717.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
54.1154.11257.04-12.580.64-131.23
Capital Expenditures
-78.79-78.79-84.47-111.5-69.79-31.72
Free Cash Flow
-24.67-24.67172.56-124.09-69.15-162.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
80.03%80.03%77.23%71.85%69.86%67.71%
Operating Margin
8.69%8.69%13.03%1.37%5.30%6.45%
Pretax Margin
10.11%10.11%10.78%2.87%6.49%6.36%
Profit Margin
8.41%8.41%7.78%1.99%4.87%4.64%
FCF Margin
-2.31%-2.31%18.82%-12.49%-6.97%-21.81%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
22.0819.5013.8192.3751.1259.10
P/FCF Ratio
--5.71---
PS Ratio
1.751.641.071.842.492.74